World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
15291
World Ranking
2676
National Ranking
177

Karl S. Lang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Karl S. Lang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 234 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Karl S. Lang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Karl S. Lang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Karl S. Lang is affiliated with the University of Duisburg-Essen in Germany. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a notable concentration on Immunology, Molecular Biology, Oncology, Infectious Diseases, and Epidemiology as subfields.

Their work covers various main topics including:

  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • Cancer Immunotherapy and Biomarkers
  • Interferon and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • Immune Response and Inflammation

Among recent papers authored by Karl S. Lang are:

  • "Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells" (2020), published in Cell Reports Medicine
  • "Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression" (2022), published in Nature Communications
  • "During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes" (2022), published in Cell Reports
  • "Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy" (2020), published in Journal of Clinical Investigation
  • "Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications" (2020), published in Journal of Experimental & Clinical Cancer Research

Frequent coauthors collaborating with Karl S. Lang include:

  • Philipp A. Lang
  • Aleksandra A. Pandyra
  • Judith Lang
  • Haifeng C. Xu
  • Lamin B. Cham

Publication venues where Karl S. Lang has frequently contributed include:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cell Reports
  • Pathogens

Best Publications

  • Mechanisms of suicidal erythrocyte death.

    Karl S Lang;Philipp A Lang;Christian Bauer;Christophe Duranton

  • Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease.

    Karl S Lang;Mike Recher;Tobias Junt;Alexander A Navarini

  • Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon.

    Luisa Cervantes-Barragan;Roland Züst;Friedemann Weber;Martin Spiegel

  • IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology

    Marc Pellegrini;Thomas Calzascia;Jesse G. Toe;Simon P. Preston

  • iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS.

    David R. McIlwain;Philipp A. Lang;Philipp A. Lang;Thorsten Maretzky;Koichi Hamada

  • Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity

    Philipp A. Lang;Karl S. Lang;Haifeng C. Xu;Melanie Grusdat

  • Enhanced Erythrocyte Apoptosis in Sickle Cell Anemia, Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency

    Karl S Lang;Benjamin Roll;Svetlana Myssina;Markus Schittenhelm

  • Aggravation of viral hepatitis by platelet-derived serotonin

    Philipp A. Lang;Claudio Contaldo;Panco Georgiev;Ashraf Mohammad El-Badry

  • Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus.

    Nadine Honke;Namir Shaabani;Giuseppe Cadeddu;Ursula R Sorg

  • Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.

    Haifeng C. Xu;Haifeng C. Xu;Melanie Grusdat;Aleksandra A. Pandyra;Robin Polz

  • Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation.

    Karl S. Lang;Mike Recher;Alexander A. Navarini;Nicola L. Harris

  • HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA/MART1

    Karl Sebastian Lang;Constanze Charlotte Caroli;Alexandra Muhm;Dorothee Wernet

  • Antigen kinetics determines immune reactivity.

    Pål Johansen;Tazio Storni;Lorna Rettig;Zhiyong Qiu

  • Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

    Karl S. Lang;Panco Georgiev;Mike Recher;Alexander A. Navarini

  • Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors

    Max Löhning;Max Löhning;Ahmed N. Hegazy;Daniel D. Pinschewer;Dorothea Busse

  • Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells.

    Alexander Carpinteiro;Michael J. Edwards;Markus Hoffmann;Markus Hoffmann;Georg Kochs

  • Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte.

    Verena B Brand;Ciprian D Sandu;Christophe Duranton;Valerie Tanneur

  • Inhibition of Erythrocyte Cation Channels by Erythropoietin

    Svetlana Myssina;Stephan M. Huber;Christina Birka;Philipp A. Lang

  • Conjugated bilirubin triggers anemia by inducing erythrocyte death.

    Elisabeth Lang;Sergios Gatidis;Noemi F. Freise;Hans Bock

  • Cooperative Phagocytes: Resident Microglia and Bone Marrow Immigrants Remove Dead Photoreceptors in Retinal Lesions

    Sandrine Joly;Mike Francke;Elke Ulbricht;Susanne Beck

  • Inactivation of TGFβ signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome

    Heiko Wurdak;Lars M. Ittner;Karl S. Lang;Per Leveen

Frequent Co-Authors

Philipp A. Lang
Philipp A. Lang Heinrich Heine University Düsseldorf
Dieter Häussinger
Dieter Häussinger Heinrich Heine University Düsseldorf
Florian Lang
Florian Lang University of Tübingen
Pamela S. Ohashi
Pamela S. Ohashi Princess Margaret Cancer Centre
Tak W. Mak
Tak W. Mak Princess Margaret Cancer Centre
Stephan M. Huber
Stephan M. Huber University of Tübingen
Rolf M. Zinkernagel
Rolf M. Zinkernagel University of Zurich
Hans Hengartner
Hans Hengartner University of Zurich
Thomas Wieder
Thomas Wieder University of Tübingen
Ulf Dittmer
Ulf Dittmer University of Duisburg-Essen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students transition into nursing through online accelerated nursing programs for non nurses, which provide a fast-tracked pathway to enter the nursing field without prior experience.

Similarly, accelerated BSN programs for non nurses offer approachable pathways for those aiming to earn a Bachelor of Science in Nursing quickly. These programs often emphasize clinical skills alongside immunology knowledge, crucial for patient care roles.

For individuals considering entry-level positions, easy admission LPN programs provide accessible routes to licensure as a Licensed Practical Nurse. This role offers valuable hands-on experience in healthcare settings that closely relate to immunology practice areas.

Advanced options include the easiest FNP program, which prepares students to become Family Nurse Practitioners. This profession merges nursing science with immunological expertise, perfect for those wanting to impact patient health at a higher level.

Best Scientists Citing Karl S. Lang

Trending Scientists

Recently Published Articles